CVS Health (CVS) is a publicly traded Healthcare sector company. As of November 15, 2026, CVS trades at $89.35 with a market cap of $114.32B and a P/E ratio of 13.30. CVS moved -0.49% today. Year to date, CVS is +11.10%; over the trailing twelve months it is +12.76%. Its 52-week range spans $58.35 to $110.68. Analyst consensus is strong buy with an average price target of $111.25. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CVS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $89.35 |
| Market Cap | $114.32B |
| P/E Ratio | 13.30 |
| EPS | $6.49 |
| Dividend Yield | 0.67% |
| 52-Week High | $110.68 |
| 52-Week Low | $58.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $357.78B |
| Net Income | $8.37B |
| Gross Margin | 39.32% |
17 analysts cover CVS: 0 strong buy, 16 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $111.25.